Correction: HIV-associated disruption of tight and adherens junctions of oral epithelial cells facilitates HSV-1 infection and spread (PLoS ONE (2014) 9, 2 (e88803) DOI: 10.1371/journal.pone.0088803);HIV-associated disruption of tight and adherens junctions of oral epithelial cells facilitates HSV-1 infection and spread

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Sufiawati, Irna ^a,c   Tugizov, Sharof M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PADJADJARAN UNIVERSITY   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN D; GLYCOPROTEIN GP 120; MITOGEN ACTIVATED PROTEIN KINASE; NECTIN 1; PROTEIN ANTIBODY; TRANSACTIVATOR PROTEIN; CELL ADHESION MOLECULE; GLYCOPROTEIN D, HUMAN HERPESVIRUS 1; NECTINS; VIRUS ENVELOPE PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CELL DISRUPTION; CELL JUNCTION; CONTROLLED STUDY; EPITHELIUM CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MOUTH LESION; MOUTH MUCOSA; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRION; VIRUS CELL INTERACTION; VIRUS TRANSMISSION; CELL CULTURE; COMPLICATION; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; HERPES SIMPLEX; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MOUTH; PATHOLOGY; PHYSIOLOGY; TIGHT JUNCTION; TRANSMISSION; VIROLOGY; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELLS, CULTURED; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GENE PRODUCTS, TAT; HERPES SIMPLEX; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; MAP KINASE SIGNALING SYSTEM; MOUTH; TIGHT JUNCTIONS; VIRAL ENVELOPE PROTEINS;

EID: 84896777815     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098724     Document Type: Erratum

References (135)

1. Wald A, Ericsson M, Krantz E, Selke S, Corey L (2004) Oral shedding of herpes simplex virus type 2. Sexually transmitted infections 80: 272-276. (Pubitemid 39070787)
2. Corey L, Wald A, Celum CL, Quinn TC (2004) The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 35: 435-445. (Pubitemid 38420652)
3. Van de Perre P, Segondy M, Foulongne V, Ouedraogo A, Konate I, et al. (2008) Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect Dis 8: 490-497. (Pubitemid 352005823)
4. Mbopi-Keou FX, Belec L, Teo CG, Scully C, Porter SR (2002) Synergism between HIV and other viruses in the mouth. Lancet Infect Dis 2: 416-424. (Pubitemid 34693259)
5. Griffin E, Krantz E, Selke S, Huang ML, Wald A (2008) Oral mucosal reactivation rates of herpesviruses among HIV-1 seropositive persons. J Med Virol 80: 1153-1159. (Pubitemid 351705993)
6. Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF (2009) HIV-associated lymphomas and gamma-herpesviruses. Blood 113: 1213-1224.
7. Leigh JE, Shetty K, Fidel PL, Jr. (2004) Oral opportunistic infections in HIV-positive individuals: review and role of mucosal immunity. AIDS Patient Care STDS 18: 443-456. (Pubitemid 39129275)
8. Posavad CM, Wald A, Kuntz S, Huang ML, Selke S, et al. (2004) Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy. The Journal of infectious diseases 190: 693-696. (Pubitemid 39049997)
9. Dinotta F, De Pasquale R, Nasca MR, Tedeschi A, Micali G (2009) Disseminated herpes simplex infection in a HIV+ patient. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 144: 205-209.
10. Kebede Y, Dorigo-Zetsma W, Mengistu Y, Mekonnen Y, Schaap A, et al. (2004) Transmission of herpes simplex virus Type 2 among factory workers in Ethiopia. The Journal of infectious diseases 190: 365-372. (Pubitemid 38951979)
11. Levy JA (2009) HIV pathogenesis: 25 years of progress and persistent challenges. AIDS 23: 147-160.
12. Feller L, Lemmer J (2007) Aspects of immunopathogenic mechanisms of HIV infection. SADJ 62: 432-434, 436.
13. Feller L, Khammissa RA, Wood NH, Meyerov R, Lemmer J (2008) Insights into immunopathogenic mechanisms of HIV infection: high levels of immune activation and HIV fitness. SADJ 63: 552, 554, 556-557.
14. Roizman B, Whitley RJ, Lopez C, editors (1993) The Human Herpesviruses. New York: Raven Press.
15. Tugizov SM, Herrera R, Chin-Hong P, Veluppillai P, Greenspan D, et al. (2013) HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus. Virology 446: 378-388.
16. Kapembwa MS, Fleming SC, Orr M, Wells C, Bland M, et al. (1996) Impaired absorption of zidovudine in patients with AIDS-related small intestinal disease. Aids 10: 1509-1514. (Pubitemid 26370664)
17. Obinna FC, Cook G, Beale T, Dave S, Cunningham D, et al. (1995) Comparative assessment of small intestinal and colonic permeability in HIV-infected homosexual men. Aids 9: 1009-1016.
18. Kapembwa MS, Fleming SC, Sewankambo N, Serwadda D, Lucas S, et al. (1991) Altered small-intestinal permeability associated with diarrhoea in human-immunodeficiency-virus-infected Caucasian and African subjects. Clin Sci (Lond) 81: 327-334.
19. Maingat F, Halloran B, Acharjee S, van Marle G, Church D, et al. (2011) Inflammation and epithelial cell injury in AIDS enteropathy: involvement of endoplasmic reticulum stress. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 25: 2211-2220.
20. Sankaran S, George MD, Reay E, Guadalupe M, Flamm J, et al. (2008) Rapid onset of intestinal epithelial barrier dysfunction in primary human immuno-deficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 82: 538-545. (Pubitemid 350309168)
21. Toschi E, Bacigalupo I, Strippoli R, Chiozzini C, Cereseto A, et al. (2006) HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway. Mol Biol Cell 17: 1985-1994. (Pubitemid 44011612)
22. Pu H, Tian J, Andras IE, Hayashi K, Flora G, et al. (2005) HIV-1 Tat protein-induced alterations of ZO-1 expression are mediated by redox-regulated ERK 1/2 activation. J Cereb Blood Flow Metab 25: 1325-1335. (Pubitemid 41348734)
23. Andras IE, Pu H, Tian J, Deli MA, Nath A, et al. (2005) Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells. J Cereb Blood Flow Metab 25: 1159-1170. (Pubitemid 41710742)
24. Bai L, Zhang Z, Zhang H, Li X, Yu Q, et al. (2008) HIV-1 Tat protein alter the tight junction integrity and function of retinal pigment epithelium: an in vitro study. BMC Infect Dis 8: 77.
25. Zhong Y, Smart EJ, Weksler B, Couraud PO, Hennig B, et al. (2008) Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J Neurosci 28: 7788-7796.
26. Song L, Ge S, Pachter JS (2007) Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells. Blood 109: 1515-1523. (Pubitemid 46239584)
27. Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, et al. (2007) HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab 27: 123-134. (Pubitemid 46006590)
28. Kanmogne GD, Primeaux C, Grammas P (2005) HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J Neuropathol Exp Neurol 64: 498-505. (Pubitemid 40781152)
29. Nakamuta S, Endo H, Higashi Y, Kousaka A, Yamada H, et al. (2008) Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells. J Neurovirol 14: 186-195. (Pubitemid 351895540)
30. Shin K, Fogg VC, Margolis B (2006) Tight junctions and cell polarity. Annual review of cell and developmental biology 22: 207-235.
31. Umeda K, Ikenouchi J, Katahira-Tayama S, Furuse K, Sasaki H, et al. (2006) ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell 126: 741-754. (Pubitemid 44233624)
32. Shen L, Turner JR (2005) Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. Molecular biology of the cell 16: 3919-3936. (Pubitemid 41262867)
33. Takahashi K, Nakanishi H, Miyahara M, Mandai K, Satoh K, et al. (1999) Nectin/PRR: an immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with Afadin, a PDZ domain-containing protein. The Journal of cell biology 145: 539-549. (Pubitemid 29215718)
34. Takai Y, Nakanishi H (2003) Nectin and afadin: novel organizers of intercellular junctions. Journal of cell science 116: 17-27. (Pubitemid 36113961)
35. Tiwari V, Oh MJ, Kovacs M, Shukla SY, Valyi-Nagy T, et al. (2008) Role for nectin-1 in herpes simplex virus 1 entry and spread in human retinal pigment epithelial cells. The FEBS journal 275: 5272-5285.
36. Karaba AH, Kopp SJ, Longnecker R (2011) Herpesvirus entry mediator and nectin-1 mediate herpes simplex virus 1 infection of the murine cornea. Journal of virology 85: 10041-10047.
37. Connolly SA, Landsburg DJ, Carfi A, Whitbeck JC, Zuo Y, et al. (2005) Potential nectin-1 binding site on herpes simplex virus glycoprotein d. Journal of virology 79: 1282-1295. (Pubitemid 40053910)
38. Krummenacher C, Baribaud F, Ponce de Leon M, Baribaud I, Whitbeck JC, et al. (2004) Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus. Virology 322: 286-299. (Pubitemid 38521143)
39. Gianni T, Campadelli-Fiume G, Menotti L (2004) Entry of herpes simplex virus mediated by chimeric forms of nectin1 retargeted to endosomes or to lipid rafts occurs through acidic endosomes. Journal of virology 78: 12268-12276. (Pubitemid 39458746)
40. Cocchi F, Lopez M, Dubreuil P, Campadelli Fiume G, Menotti L (2001) Chimeric nectin1-poliovirus receptor molecules identify a nectin1 region functional in herpes simplex virus entry. Journal of virology 75: 7987-7994. (Pubitemid 32743670)
41. Struyf F, Posavad CM, Keyaerts E, Van Ranst M, Corey L, et al. (2002) Search for polymorphisms in the genes for herpesvirus entry mediator, nectin-1, and nectin-2 in immune seronegative individuals. The Journal of infectious diseases 185: 36-44. (Pubitemid 34043014)
42. Krummenacher C, Nicola AV, Whitbeck JC, Lou H, Hou W, et al. (1998) Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry. Journal of virology 72: 7064-7074. (Pubitemid 28377834)
43. Yoon M, Spear PG (2002) Disruption of adherens junctions liberates nectin-1 to serve as receptor for herpes simplex virus and pseudorabies virus entry. Journal of virology 76: 7203-7208.
44. Xiao J, Palefsky JM, Herrera R, Berline J, Tugizov SM (2009) EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells. Virology 388: 335-343.
45. Tugizov SM, Herrera R, Palefsky JM (2013) Epstein-Barr Virus Transcytosis through Polarized Oral Epithelial Cells. Journal of virology 87: 8179-8194.
46. Tugizov SM, Herrera R, Veluppillai P, Greenspan D, Soros V, et al. (2011) HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells. Virology 409: 211-222.
47. Tugizov SM, Berline JW, Palefsky JM (2003) Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med 9: 307-314. (Pubitemid 36362786)
48. Gulino D, Delachanal E, Concord E, Genoux Y, Morand B, et al. (1998) Alteration of endothelial cell monolayer integrity triggers resynthesis of vascular endothelium cadherin. J Biol Chem 273: 29786-29793. (Pubitemid 28509991)
49. Tugizov SM, Herrera R, Veluppillai P, Greenspan D, Soros V, et al. (2012) Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia. Journal of virology 86: 2556-2570.
50. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, et al. (2010) Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS pathogens 6: e1000852.
51. Navarro D, Paz P, Pereira L (1992) Domains of herpes simplex virus 1 glycoprotein B that function in virion penetration, cell-to-cell spread, and cell fusion. Virology 186: 99-112.
52. Sisk WP, Bradley JD, Leipold RJ, Stoltzfus AM, Ponce de Leon M, et al. (1994) High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells. Journal of virology 68: 766-775. (Pubitemid 24022179)
53. Krautkramer E, Zeier M (2008) Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55). Journal of virology 82: 4257-4264. (Pubitemid 351563663)
54. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, et al. (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375: 497-500.
55. Xiao H, Neuveut C, Tiffany HL, Benkirane M, Rich EA, et al. (2000) Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A 97: 11466-11471.
56. Rychert J, Strick D, Bazner S, Robinson J, Rosenberg E (2010) Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines. AIDS research and human retroviruses 26: 1139-1145.
57. Poggi A, Zocchi MR (2006) HIV-1 Tat triggers TGF-beta production and NK cell apoptosis that is prevented by pertussis toxin B. Clinical & developmental immunology 13: 369-372. (Pubitemid 44950053)
58. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, et al. (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 4: 1449-1452. (Pubitemid 28553472)
59. Barillari G, Sgadari C, Fiorelli V, Samaniego F, Colombini S, et al. (1999) The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood 94: 663-672. (Pubitemid 29323880)
60. Barillari G, Sgadari C, Palladino C, Gendelman R, Caputo A, et al. (1999) Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. J Immunol 163: 1929-1935. (Pubitemid 29382194)
61. Su YH, Zhang X, Wang X, Fraser NW, Block TM (2006) Evidence that the immediate-early gene product ICP4 is necessary for the genome of the herpes simplex virus type 1 ICP4 deletion mutant strain d120 to circularize in infected cells. Journal of virology 80: 11589-11597. (Pubitemid 44788873)
62. Watson K, Edwards RJ (1999) HIV-1-trans-activating (Tat) protein: both a target and a tool in therapeutic approaches. Biochem Pharmacol 58: 1521-1528. (Pubitemid 29467336)
63. Vogel BE, Lee SJ, Hildebrand A, Craig W, Pierschbacher MD, et al. (1993) A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol 121: 461-468. (Pubitemid 23110888)
64. Trushin SA, Algeciras-Schimnich A, Vlahakis SR, Bren GD, Warren S, et al. (2007) Glycoprotein 120 binding to CXCR4 causes p38-dependent primary T cell death that is facilitated by, but does not require cell-associated CD4. Journal of immunology 178: 4846-4853. (Pubitemid 46595266)
65. Kinet S, Bernard F, Mongellaz C, Perreau M, Goldman FD, et al. (2002) gp120-mediated induction of the MAPK cascade is dependent on the activation state of CD4(+) lymphocytes. Blood 100: 2546-2553.
66. Kuang YQ, Pang W, Zheng YT, Dupre DJ (2012) NHERF1 regulates gp120-induced internalization and signaling by CCR5, and HIV-1 production. European journal of immunology 42: 299-310.
67. Lee C, Liu QH, Tomkowicz B, Yi Y, Freedman BD, et al. (2003) Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. Journal of leukocyte biology 74: 676-682. (Pubitemid 38040343)
68. Xiao J, Palefsky JM, Herrera R, Tugizov SM (2007) Characterization of the Epstein-Barr virus glycoprotein BMRF-2. Virology 359: 382-396. (Pubitemid 46274876)
69. Chen Y, Lu Q, Schneeberger EE, Goodenough DA (2000) Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Molecular biology of the cell 11: 849-862. (Pubitemid 30159306)
70. Kuphal S, Poser I, Jobin C, Hellerbrand C, Bosserhoff AK (2004) Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene 23: 8509-8519. (Pubitemid 39540801)
71. Krummenacher C, Baribaud I, Ponce de Leon M, Whitbeck JC, Lou H, et al. (2000) Localization of a binding site for herpes simplex virus glycoprotein D on herpesvirus entry mediator C by using antireceptor monoclonal antibodies. Journal of virology 74: 10863-10872. (Pubitemid 32223950)
72. Montgomery RI, Warner MS, Lum BJ, Spear PG (1996) Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87: 427-436. (Pubitemid 26374317)
73. Shieh MT, WuDunn D, Montgomery RI, Esko JD, Spear PG (1992) Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. The Journal of cell biology 116: 1273-1281.
74. Terry-Allison T, Montgomery RI, Whitbeck JC, Xu R, Cohen GH, et al. (1998) HveA (herpesvirus entry mediator A), a coreceptor for herpes simplex virus entry, also participates in virus-induced cell fusion. Journal of virology 72: 5802-5810. (Pubitemid 28283366)
75. Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, et al. (1999) A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99: 13-22. (Pubitemid 29468626)
76. Even DL, Henley AM, Geraghty RJ (2006) The requirements for herpes simplex virus type 1 cell-cell spread via nectin-1 parallel those for virus entry. Virus research 119: 195-207. (Pubitemid 43765986)
77. Cocchi F, Menotti L, Dubreuil P, Lopez M, Campadelli-Fiume G (2000) Cell-to-cell spread of wild-type herpes simplex virus type 1, but not of syncytial strains, is mediated by the immunoglobulin-like receptors that mediate virion entry, nectin1 (PRR1/HveC/HIgR) and nectin2 (PRR2/HveB). Journal of virology 74: 3909-3917. (Pubitemid 30180336)
78. Krummenacher C, Baribaud I, Eisenberg RJ, Cohen GH (2003) Cellular localization of nectin-1 and glycoprotein D during herpes simplex virus infection. J Virol 77: 8985-8999. (Pubitemid 36939158)
79. Epple HJ, Schneider T, Troeger H, Kunkel D, Allers K, et al. (2009) Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 58: 220-227.
80. Remeijer L, Maertzdorf J, Buitenwerf J, Osterhaus AD, Verjans GM (2002) Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis. Investigative ophthalmology & visual science 43: 358-363. (Pubitemid 34113215)
81. Sucato G, Wald A, Wakabayashi E, Vieira J, Corey L (1998) Evidence of latency and reactivation of both herpes simplex virus (HSV)-1 and HSV-2 in the genital region. The Journal of infectious diseases 177: 1069-1072. (Pubitemid 28155164)
82. Buchman TG, Roizman B, Nahmias AJ (1979) Demonstration of exogenous genital reinfection with herpes simplex virus type 2 by restriction endonuclease fingerprinting of viral DNA. The Journal of infectious diseases 140: 295-304. (Pubitemid 10189470)
83. Maertzdorf J, Remeijer L, Van Der Lelij A, Buitenwerf J, Niesters HG, et al. (1999) Amplification of reiterated sequences of herpes simplex virus type 1 (HSV-1) genome to discriminate between clinical HSV-1 isolates. Journal of clinical microbiology 37: 3518-3523. (Pubitemid 29491085)
84. Stanberry LR, Cunningham AL, Mindel A, Scott LL, Spruance SL, et al. (2000) Prospects for control of herpes simplex virus disease through immunization. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 30: 549-566.
85. Roest RW, Maertzdorf J, Kant M, van der Meijden WI, Osterhaus AD, et al. (2006) High incidence of genotypic variance between sequential herpes simplex virus type 2 isolates from HIV-1-seropositive patients with recurrent genital herpes. The Journal of infectious diseases 194: 1115-1118. (Pubitemid 44547651)
86. Xie L, Law BK, Chytil AM, Brown KA, Aakre ME, et al. (2004) Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 6: 603-610. (Pubitemid 39411098)
87. Lau MT, So WK, Leung PC (2013) Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells. PloS one 8: e59083.
88. Stadler SC, Allis CD (2012) Linking epithelial-to-mesenchymal-transition and epigenetic modifications. Seminars in cancer biology 22: 404-410.
89. Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE (2000) HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney international 58: 173-181. (Pubitemid 30429862)
90. Schwartz EJ, Cara A, Snoeck H, Ross MD, Sunamoto M, et al. (2001) Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. Journal of the American Society of Nephrology : JASN 12: 1677-1684. (Pubitemid 32674430)
91. Medapalli RK, He JC, Klotman PE (2011) HIV-associated nephropathy: pathogenesis. Current opinion in nephrology and hypertension 20: 306-311.
92. Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, et al. (2000) Renal epithelium is a previously unrecognized site of HIV-1 infection. Journal of the American Society of Nephrology : JASN 11: 2079-2087.
93. Lu TC, He JC, Wang ZH, Feng X, Fukumi-Tominaga T, et al. (2008) HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein. The Journal of biological chemistry 283: 8173-8182.
94. Takai Y, Irie K, Shimizu K, Sakisaka T, Ikeda W (2003) Nectins and nectin-like molecules: roles in cell adhesion, migration, and polarization. Cancer science 94: 655-667. (Pubitemid 37160921)
95. Cocchi F, Lopez M, Menotti L, Aoubala M, Dubreuil P, et al. (1998) The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D. Proceedings of the National Academy of Sciences of the United States of America 95: 15700-15705. (Pubitemid 29018763)
96. Krummenacher C, Rux AH, Whitbeck JC, Ponce-de-Leon M, Lou H, et al. (1999) The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC. Journal of virology 73: 8127-8137. (Pubitemid 29441673)
97. Nicola AV, Straus SE (2004) Cellular and viral requirements for rapid endocytic entry of herpes simplex virus. Journal of virology 78: 7508-7517. (Pubitemid 38915896)
98. Pertel PE, Fridberg A, Parish ML, Spear PG (2001) Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. Virology 279: 313-324. (Pubitemid 34161021)
99. Delboy MG, Patterson JL, Hollander AM, Nicola AV (2006) Nectin-2-mediated entry of a syncytial strain of herpes simplex virus via pH-independent fusion with the plasma membrane of Chinese hamster ovary cells. Virology journal 3: 105.
100. Smith JS, Robinson NJ (2002) Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. The Journal of infectious diseases 186 Suppl 1: S3-28.
101. Andreoletti L, Piednoir E, Legoff J, Brodard V, Beguinot I, et al. (2005) High seroprevalence of herpes simplex virus type 2 infection in French human immunodeficiency virus type 1-infected outpatients. Journal of clinical microbiology 43: 4215-4217. (Pubitemid 41129731)
102. Chakraborty N, Bhattacharyya S, De C, Mukherjee A, Bhattacharya D, et al. (2010) Incidence of multiple Herpesvirus infection in HIV seropositive patients, a big concern for Eastern Indian scenario. Virology journal 7: 147.
103. Turner KR, McFarland W, Kellogg TA, Wong E, Page-Shafer K, et al. (2003) Incidence and prevalence of herpes simplex virus type 2 infection in persons seeking repeat HIV counseling and testing. Sexually transmitted diseases 30: 331-334. (Pubitemid 36397835)
104. Hagan H, Jenness SM, Wendel T, Murrill CR, Neaigus A, et al. (2010) Herpes simplex virus type 2 associated with HIV infection among New York heterosexuals living in high-risk areas. International journal of STD & AIDS 21: 580-583.
105. Shukla SY, Singh YK, Shukla D (2009) Role of nectin-1, HVEM, and PILR-alpha in HSV-2 entry into human retinal pigment epithelial cells. Investigative ophthalmology & visual science 50: 2878-2887.
106. Rodriguez-Inigo E, Jimenez E, Bartolome J, Ortiz-Movilla N, Bartolome Villar B, et al. (2005) Detection of human immunodeficiency virus type 1 RNA by in situ hybridization in oral mucosa epithelial cells from anti-HIV-1 positive patients. J Med Virol 77: 17-22. (Pubitemid 41076471)
107. Chou LL, Epstein J, Cassol SA, West DM, He W, et al. (2000) Oral mucosal Langerhans' cells as target, effector and vector in HIV infection. J Oral Pathol Med 29: 394-402. (Pubitemid 30648012)
108. Goto Y, Yeh CK, Notkins AL, Prabhakar BS (1991) Detection of proviral sequences in saliva of patients infected with human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 7: 343-347.
109. Kakizawa J, Ushijima H, Oka S, Ikeda Y, Schroder HC, et al. (1996) Detection of human immunodeficiency virus-1 DNA, RNA and antibody, and occult blood in inactivated saliva: availability of the filter paper disk method. Acta Paediatr Jpn 38: 218-223. (Pubitemid 26243287)
110. Liuzzi G, Chirianni A, Clementi M, Bagnarelli P, Valenza A, et al. (1996) Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. Aids 10: F51-56. (Pubitemid 26394975)
111. Maticic M, Poljak M, Kramar B, Tomazic J, Vidmar L, et al. (2000) Proviral HIV-1 DNA in gingival crevicular fluid of HIV-1-infected patients in various stages of HIV disease. J Dent Res 79: 1496-1501. (Pubitemid 32489373)
112. Qureshi MN, Barr CE, Hewlitt I, Boorstein R, Kong F, et al. (1997) Detection of HIV in oral mucosal cells. Oral Dis 3 Suppl 1: S73-78. (Pubitemid 27242066)
113. Qureshi MN, Barr CE, Seshamma T, Reidy J, Pomerantz RJ, et al. (1995) Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons. J Infect Dis 171: 190-193.
114. Zuckerman RA, Whittington WL, Celum CL, Collis T, Lucchetti A, et al. (2003) Factors associated with oropharyngeal human immunodeficiency virus shedding. J Infect Dis 188: 142-145. (Pubitemid 36829754)
115. Nuovo GJ, Forde A, MacConnell P, Fahrenwald R (1993) In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues. Am J Pathol 143: 40-48. (Pubitemid 24058159)
116. Clemetson DB, Moss GB, Willerford DM, Hensel M, Emonyi W, et al. (1993) Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA : the journal of the American Medical Association 269: 2860-2864.
117. Sonza S, Mutimer HP, Oelrichs R, Jardine D, Harvey K, et al. (2001) Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. Aids 15: 17-22. (Pubitemid 32055775)
118. Henning TR, Kissinger P, Lacour N, Meyaski-Schluter M, Clark R, et al. (2010) Elevated cervical white blood cell infiltrate is associated with genital HIV detection in a longitudinal cohort of antiretroviral therapy-adherent women. The Journal of infectious diseases 202: 1543-1552.
119. Crowe SM, Sonza S (2000) HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. Journal of leukocyte biology 68: 345-350.
120. Santosuosso M, Righi E, Lindstrom V, Leblanc PR, Poznansky MC (2009) HIV-1 envelope protein gp120 is present at high concentrations in secondary lymphoid organs of individuals with chronic HIV-1 infection. The Journal of infectious diseases 200: 1050-1053.
121. Oh SK, Cruikshank WW, Raina J, Blanchard GC, Adler WH, et al. (1992) Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. Journal of acquired immune deficiency syndromes 5: 251-256.
122. Montagnier L, Clavel F, Krust B, Chamaret S, Rey F, et al. (1985) Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. Virology 144: 283-289. (Pubitemid 15226191)
123. Kaplan IM, Wadia JS, Dowdy SF (2005) Cationic TAT peptide transduction domain enters cells by macropinocytosis. Journal of controlled release : official journal of the Controlled Release Society 102: 247-253.
124. Wadia JS, Stan RV, Dowdy SF (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nature medicine 10: 310-315. (Pubitemid 38667624)
125. Mann DA, Frankel AD (1991) Endocytosis and targeting of exogenous HIV-1 Tat protein. The EMBO journal 10: 1733-1739. (Pubitemid 21905640)
126. Ferrari A, Pellegrini V, Arcangeli C, Fittipaldi A, Giacca M, et al. (2003) Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Molecular therapy : the journal of the American Society of Gene Therapy 8: 284-294.
127. Fittipaldi A, Ferrari A, Zoppe M, Arcangeli C, Pellegrini V, et al. (2003) Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. The Journal of biological chemistry 278: 34141-34149. (Pubitemid 37553255)
128. Preiss S, Namgaladze D, Brune B (2007) Critical role for classical PKC in activating Akt by phospholipase A2-modified LDL in monocytic cells. Cardiovasc Res 73: 833-840. (Pubitemid 46227357)
129. Kawakami Y, Nishimoto H, Kitaura J, Maeda-Yamamoto M, Kato RM, et al. (2004) Protein kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. J Biol Chem 279: 47720-47725. (Pubitemid 39540919)
130. Zhou H, Das S, Murthy KS (2003) Erk1/2- and p38 MAP kinase-dependent phosphorylation and activation of cPLA2 by m3 and m2 receptors. Am J Physiol Gastrointest Liver Physiol 284: G472-480. (Pubitemid 36227895)
131. Lopez-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, et al. (2005) RACK1 mediates activation of JNK by protein kinase C [corrected]. Mol Cell 19: 309-320. (Pubitemid 41074887)
132. Ali AS, Ali S, El-Rayes BF, Philip PA, Sarkar FH (2009) Exploitation of protein kinase C: a useful target for cancer therapy. Cancer Treat Rev 35: 1-8.
133. Marshall CJ (1996) Cell signalling. Raf gets it together. Nature 383: 127-128.
134. Cai H, Smola U, Wixler V, Eisenmann-Tappe I, Diaz-Meco MT, et al. (1997) Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol Cell Biol 17: 732-741. (Pubitemid 27044372)
135. Wang Y, Zhang J, Yi XJ, Yu FS (2004) Activation of ERK1/2 MAP kinase pathway induces tight junction disruption in human corneal epithelial cells. Exp Eye Res 78: 125-136. (Pubitemid 37518251)